BamSEC and AlphaSense Join Forces
Learn More

Northwest Biotherapeutics Inc

OTC: NWBO    
Share price (12/24/24): $0.26    
Market cap (12/24/24): $337 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.89
from 10-K 9 pages C O M M E R C Ia L Lo a N AG R E E M E N T
12/34/56
EX-10.88
from 10-K 6 pages Commercial Promissory Note
12/34/56
EX-10.87
from 10-K 6 pages ​ Sub-Lease Agreement ​
12/34/56
EX-10.86
from 10-K 16 pages Co M M E R C I a L Lo a N AG R E E M E N T
12/34/56
EX-10.83
from 10-K 97 pages Unit Purchase Agreement
12/34/56
EX-10.82
from 10-K 21 pages ​ Note Purchase Agreement
12/34/56
EX-10.81
from 10-K 9 pages Northwest Biotherapeutics, Inc. ​ 2020 Equity Compensation Plan
12/34/56
EX-10.80
from 10-K 36 pages Lease Relating to Vision Centre, Sawston, Cambridge Dated: 14 December 2018 Between Aracaris Capital Limited and Aracaris Limited Cms Cameron McKenna Nabarro Olswang Llp Cannon Place 78 Cannon Street London Ec4n 6af T +44 20 7367 3000 F +44 20 7367 2000 CMS.LAW
12/34/56
EX-10.79
from 10-K 30 pages Asset Sale Contract
12/34/56
EX-10.78
from 10-K 5 pages Form of Unsecured Promissory Note Agreement Plus Warrant
12/34/56
EX-10.77
from 10-K 7 pages Northwest Biotherapeutics, Inc 6% Convertible Secured Full Recourse Redeemable Note Due August 25, 2018
12/34/56
EX-10.74
from 10-K 8 pages Settlement and Amendment Agreement
12/34/56
EX-10.73
from 10-K 35 pages Settlement and Amendment Agreement
12/34/56
EX-10.2
from 8-K 17 pages Form of Common Stock Purchase Warrant Class D-3 Northwest Biotherapeutics, Inc
12/34/56
EX-10.1
from 8-K 5 pages Agreement
12/34/56
EX-10.69
from 10-K 49 pages Date: 10 October 2017 Lease Relating to Cdc Warehouse, Sawston, Cambridge Between Aracaris Capital Limited and Routebuy Limited and Commodity Centre (Group) Limited Cms Cameron McKenna Nabarro Olswang Llp Cannon Place 78 Cannon Street London Ec4n 6af T +44 20 7367 3000 F +44 20 7367 2000 CMS.LAW
12/34/56
EX-10.3
from 8-K 6 pages Northwest Biotherapeutics, Inc. Subscription Agreement
12/34/56
EX-10.2
from 8-K 6 pages Voting Agreement
12/34/56
EX-10.1
from 8-K 9 pages Northwest Biotherapeutics, Inc. Class D-2 Warrants
12/34/56
EX-10.3
from 8-K 10 pages Northwest Biotherapeutics, Inc. Subscription Agreement
12/34/56